Corporate Accountability in the Opioid Crisis

This chapter examines the controversial role of McKinsey & Company during the opioid crisis, focusing on their collusion with Purdue Pharma to promote OxyContin sales despite known risks. It critiques the Biden administration's handling of corporate malpractice and the introduction of policies that seemingly enable companies to self-report crimes without facing significant consequences. The discussion underscores the devastating societal impacts of unregulated corporate practices on public health and highlights the urgent need for accountability in both government and the private sector.